Decipher Biosciences
Decipher Biosciences, a Veracyte company, provides a genomic test that measures the molecular profile of bladder cancer using gene expression analysis from transurethral resected bladder cancer specimens.
Year Established: 2008
Stock Ticker: VCYT
Exchange: NASDAQ
Locations
Decipher Biosciences
San Diego CADecipher Biosciences, a Veracyte company, provides a genomic test that measures the molecular profile of bladder cancer using gene expression analysis from transurethral resected bladder cancer specimens.
Decipher Biosciences
San Francisco CADecipher Biosciences, a Veracyte company, provides a genomic test that measures the molecular profile of bladder cancer using gene expression analysis from transurethral resected bladder cancer specimens.
